Thousand Oaks, CA, United States of America

Junfen Ma

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Junfen Ma in Antigen-Binding Protein Production

Introduction

Junfen Ma is a prominent inventor based in Thousand Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the production of antigen-binding proteins. With a total of three patents to her name, her work has advanced the methods used in this critical area of research.

Latest Patents

Junfen Ma's latest patents include innovative methods for the production of antigen-binding proteins. One of her patents focuses on a method of re-oxidizing an antigen-binding protein. This method enhances the quality and efficacy of the proteins produced. Another patent details charged depth filtration techniques for antigen-binding proteins. This method involves contacting an aqueous solution containing antigen-binding protein molecules with a charged depth filter. The process is designed to improve the re-oxidation of these proteins, resulting in a decrease in the percentage of reduced antigen-binding protein molecules.

Career Highlights

Junfen Ma is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to collaborate with other talented professionals in the field. She has been instrumental in developing methods that enhance the production and formulation of therapeutic proteins.

Collaborations

Some of her notable coworkers include Xiaoyang Zhao and Brian Williamson. Their collaborative efforts have contributed to the advancement of techniques in protein production and formulation.

Conclusion

Junfen Ma's innovative work in the field of antigen-binding proteins has led to significant advancements in biotechnology. Her patents reflect her commitment to improving methods that are essential for the development of therapeutic proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…